$0.3110
-0.02-5.76%
At close: -
$0.3319
0.026.72%
After Hours: 8:00 AM EDT
Comments
Loading...
Avenue Therapeutics Earnings Estimates, EPS & Revenue | OTC:ATXI | Benzinga
Avenue Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-1.920
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Avenue Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATXI | Avenue Therapeutics | -$15.40 | — | — | — | $0.00 | — | — | — | 05/14/2025 | Get Alert |
| ATXI | Avenue Therapeutics | $42.00 | — | — | — | $0.00 | — | — | — | 04/11/2025 | Get Alert |
| ATXI | Avenue Therapeutics | $4.86 | -$0.94 | -$1.92 | -104.26% | $0.00 | — | $0.00 | — | 11/14/2024 | Get Alert |
| ATXI | Avenue Therapeutics | -$38.74 | -$1.05 | -$6.43 | -512.38% | $0.00 | — | $0.00 | — | 08/09/2024 | Get Alert |
| ATXI | Avenue Therapeutics | -$101.57 | -$9.00 | -$15.40 | -71.11% | $0.00 | — | $0.00 | — | 05/15/2024 | Get Alert |
| ATXI | Avenue Therapeutics | -$92.25 | -$7.50 | $2.25 | 130.00% | $0.00 | — | $0.00 | — | 03/18/2024 | Get Alert |
| ATXI | Avenue Therapeutics | -$33.75 | -$19.50 | $4.50 | 123.08% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
| ATXI | Avenue Therapeutics | -$33.75 | -$21.75 | -$39.00 | -79.31% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| ATXI | Avenue Therapeutics | -$157.50 | — | -$102.75 | — | $0.00 | — | $0.00 | — | 05/12/2023 | Get Alert |
| ATXI | Avenue Therapeutics | -$56.25 | — | -$92.25 | — | $0.00 | — | $0.00 | — | 03/30/2023 | Get Alert |
| ATXI | Avenue Therapeutics | -$59.25 | — | -$33.75 | — | $0.00 | — | $0.00 | — | 11/10/2022 | Get Alert |
| ATXI | Avenue Therapeutics | -$67.50 | — | -$33.75 | — | $0.00 | — | $0.00 | — | 08/15/2022 | Get Alert |
| ATXI | Avenue Therapeutics | -$67.50 | — | -$157.50 | — | $0.00 | — | $0.00 | — | 05/16/2022 | Get Alert |
| ATXI | Avenue Therapeutics | -$67.50 | — | -$56.25 | — | $0.00 | — | $0.00 | — | 03/25/2022 | Get Alert |
| ATXI | Avenue Therapeutics | -$67.50 | -$56.25 | -$56.25 | 0.00% | $0.00 | — | $0.00 | — | 11/15/2021 | Get Alert |
| ATXI | Avenue Therapeutics | -$123.75 | — | -$67.50 | — | $0.00 | — | $0.00 | — | 08/16/2021 | Get Alert |
| ATXI | Avenue Therapeutics | -$90.00 | — | -$67.50 | — | $0.00 | — | $0.00 | — | 05/17/2021 | Get Alert |
| ATXI | Avenue Therapeutics | -$371.25 | -$78.75 | -$67.50 | 14.29% | $0.00 | — | $0.00 | — | 03/31/2021 | Get Alert |
| ATXI | Avenue Therapeutics | -$157.50 | — | -$67.50 | — | $0.00 | — | $0.00 | — | 11/04/2020 | Get Alert |
| ATXI | Avenue Therapeutics | -$483.75 | — | -$123.75 | — | $0.00 | — | $0.00 | — | 08/14/2020 | Get Alert |
| ATXI | Avenue Therapeutics | -$922.50 | -$191.25 | -$90.00 | 52.94% | $0.00 | — | $0.00 | — | 05/11/2020 | Get Alert |
| ATXI | Avenue Therapeutics | -$416.25 | — | -$371.25 | — | $0.00 | — | $0.00 | — | 03/30/2020 | Get Alert |
Avenue Therapeutics (ATXI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-1.92 | $-0.94 | -104.3 % |
| Q2 | 2024-08-09 | $-6.43 | $-1.05 | -512.4 % |
| Q1 | 2024-05-15 | $-15.40 | $-9.00 | -71.1 % |
| Q4 | 2024-03-18 | $2.25 | $-7.50 | 130.0 % |
Avenue Therapeutics (ATXI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Avenue Therapeutics (OTCPK:ATXI) reporting earnings?
Avenue Therapeutics (ATXI) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Avenue Therapeutics (OTCPK:ATXI)?
The Actual EPS was $-1.92, which missed the estimate of $-0.94.
What were Avenue Therapeutics’s (OTCPK:ATXI) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.